Trending

John Fetterman is trending now Karen Read is trending now Florida Panthers is trending now Georgia baseball is trending now Malawi is trending now Tony Evans is trending now Rebecca Grossman is trending now iOS 18 beta is trending now Maren Morris is trending now Nvidia stock price is trending now iOS 18 beta is trending now Maren Morris is trending now John Fetterman is trending now Karen Read is trending now Florida Panthers is trending now Georgia baseball is trending now Malawi is trending now Tony Evans is trending now Rebecca Grossman is trending now iOS 18 beta is trending now Maren Morris is trending now Nvidia stock price is trending now iOS 18 beta is trending now Maren Morris is trending now

Health

Inhibrx announces positive interim results from HexAgon trial

H Hospital Management · 2 months ago · 41 views

Inhibrx Biosciences has reported positive interim data from the Phase II segment of its HexAgon study assessing INBRX-106 in treatment-naÃ¯ve, PD-L1 positive metastatic or unresectable recurrent HNSCC. The post Inhibrx announces positive interim results from HexAgon trial appeared first on Hospital Management.

The post Inhibrx announces positive interim results from HexAgon trial appeared first on Hospital Management.

View original source →

Health